Evidence map›Paper›PMID 40297714›Full record

ArticleDegenerative neurological and neuromuscular disease2025

Based on the Dual Pathway of Interaction-Mediated NF-κB in Cell Apoptosis and Immune Inflammation to Study the Effect of Danzhi Xiaoyao Powder on the Learning and Cognitive Ability of AD Model Rats.

Hu-Ping Wang, Ming-Cheng Li, Jiao Yang, Jun Zhou, Zhi-Peng Meng, Yun-Yun Hu, Yu-Jie Lyu, Yi-Qin Chen, Yu-Mei Han, Wen-Li Pei

Abstract read
In one paragraph

Article in Degenerative neurological and neuromuscular disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Computational Analysis andCurrent medicinal chemistry · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hu-Ping Wang *School of Basic Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou, People's Republic of China.
Ming-Cheng Li *Qujing 69 Hospital, China RongTong Medical Healthcare Group Co. Ltd., Qujing, People's Republic of China.
Jiao YangSchool of Basic Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou, People's Republic of China.
Jun ZhouPreventive Medicine Department, Xichang Hospital of Traditional Chinese Medicine, Xichang, People's Republic of China.ORCID 0009-0005-1158-1167
Zhi-Peng MengSchool of Basic Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou, People's Republic of China.
Yun-Yun HuSchool of Basic Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou, People's Republic of China.
Yu-Jie LyuSchool of Basic Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou, People's Republic of China.
Yi-Qin ChenSchool of Basic Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou, People's Republic of China.
Yu-Mei HanSchool of Basic Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou, People's Republic of China.
Wen-Li PeiSchool of Basic Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Apoptosis and immune inflammation play important roles in the pathological process of Alzheimer's disease (AD), but their specific pathogenesis is still unclear. Therefore, this article focuses on exploring the effects of Danzhi Xiaoyao Powder (DXP) on the learning and memory ability of AD model rats from the dual mechanisms of apoptosis and immune inflammation. Methods: The AD model was replicated by injecting Okadaic acid (100 ng) into the bilateral hippocampus of rats. Successful rats were selected and orally administered with donepezil hydrochloride and DXP decoction for 42 days. Their learning and memory abilities, hippocampal morphology, Aβ expression, inflammatory factors, apoptotic factors, anti apoptotic factors, as well as the expression of pathway proteins and mRNA were detected. Results: After DXP intervention, the learning and memory abilities of rats improved, the neuronal cell arrangement was more complete, the expression of Aβ decreased, the expression of pro-inflammatory cytokine and apoptotic factors decreased, the expression of anti apoptotic factors increased, Protein Kinase B (Akt) expression and activity significant up-regulation, and nuclear factor kappa-B (NF-κB), p38 MAPK (p38), MAPKAPK-2 (MK2), Cyclooxygenase-2 (COX-2) protein and mRNA expression were significantly down-regulated. Conclusion: DXP can improve the learning and cognitive abilities of AD model rats, and its mechanism of action may be related to the regulation of the Akt/NF-κB apoptosis pathway mediated by NF-κB interaction and the p38MAPK/MK2/COX-2 immune inflammatory dual pathway.

Indexed as

Akt/NF-κB signaling pathwayAlzheimer’s diseaseDanzhi Xiaoyao powderneuronal apoptosisneuronal specific inflammatory responseP38MAPK/MK2/COX2 signaling pathway

Identifiers

PMID40297714
PMCPMC12035751

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.